News and Events
Launch of the UCC CiSA (CoMH Interdisciplinary Seed Awards)
Dr. Suzanne Timmons, with Dr. Mark Rae from the Department of Physiology (centre of picture), at the recent launch of the UCC CiSA (COMH Interdisciplinary Seed Awards). Also included are Dr Michael Clarkson, CoMH VDR&I and Prof Helen Whelton, Head of College.
Thanks to the generosity of our corporate partners, including Boston Scientific, Pfizer, Laya Healthcare, and GSK, the College of Medicine and Health was able to create the CiSA programme.
The remit of CiSA is to promote the development of clinical and nonclinical researcher collaborations within the UCC CoMH and the healthcare aligned services within the SSWHG and the Bons Secours Hospital, Cork. Increasing research collaborations with our clinical colleagues is paramount to UCC and is part of our vision for CoMH.
The CoMH Research Committee was delighted to receive over 20 applications to the inaugural CiSA call, the top 7 of which will be funded. The successful teams span all 6 Schools within the CoMH, with partners from across the SSWHG.
The teams attended the Launch Event on Friday Oct 4, where they each presented their proposed research projects to academic and clinical colleagues, with Pfizer’s Global Supply Vice President of Small Molecule Operations, Dr Paul Duffy, and Boston Scientific’s Director of Process Development, Mr Joe Devlin, also in attendance. Both corporate partners were impressed with the breath and level of cross-sectoral research planned for the CiSA funds.
One of the 7 successful teams was Dr Mark G. Rae and Dr Suzanne Timmons who represent the School of Medicine and the Department of Geriatrics in the Mercy University Hospital. Their proposed project is How does cerebrospinal fluid from Alzheimer’s disease patients affect human cortical forebrain cerebroid form and function?